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Abstract
Background
The pig parasite Ascaris suum plays and important role in veterinary medicine and repre-
sents a suitable model for A. lumbricoides, which infects over 800 million people. In pigs,
continued exposure to Ascaris induces immunity at the level of the gut, protecting the host
against migrating larvae. The objective of this study was to identify and characterize parasite
antigens targeted by this local immune response that may be crucial for parasite invasion
and establishment and to evaluate their protective and diagnostic potential.
Methodology/Principal Findings
Pigs were immunized by trickle infection for 30 weeks, challenged with 2,000 eggs at week
32 and euthanized two weeks after challenge. At necropsy, there was a 100% reduction in
worms recovered from the intestine and a 97.2% reduction in liver white spots in comparison
with challenged non-immune control animals. Antibodies purified from the intestinal mucus
or from the supernatant of cultured antibody secreting cells from mesenteric lymph nodes of
immune pigs were used to probe L3 extracts to identify antibody targets. This resulted in the
recognition of a 12kDa antigen (As12) that is actively shed from infective Ascaris L3. As12
was characterized as a phosphorylcholine-containing glycolipid-like antigen that is highly
resistant to different enzymatic and chemical treatments. Vaccinating pigs with an As12
fraction did not induce protective immunity to challenge infection. However, serological anal-
ysis using sera or plasma from experimentally infected pigs or naturally infected humans
demonstrated that the As12 ELISA was able to detect long-term exposure to Ascaris with a
high diagnostic sensitivity (98.4% and 92%, respectively) and specificity (95.5% and 90.0%)
in pigs and humans, respectively.
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Conclusions/Significance
These findings show the presence of a highly stage specific, glycolipid-like component
(As12) that is actively secreted by infectious Ascaris larvae and which acts as a major anti-
body target in infected humans and pigs.
Author Summary
Roundworms infect millions of humans and pigs throughout the world. The pig round-
worm A. suum is a good model for A. lumbricoides infection in humans due to similar
host physiology and the close genetic relationship between the worms. The aim of this
study was to identify and characterize early larval antigens that are targeted by antibodies
at the level of the intestine in immune pigs and to evaluate their protective and diagnostic
potential. In order to do so, we generated highly immune pigs by repeatedly infecting
them with A. suum for a long time (32 weeks). After necropsy, locally harvested antibodies
from the gut were used to screen larval extracts. Hereby one particular antigen, named
As12, was detected. It was characterized as a molecule of glycolipid nature that is pre-
sented on, and actively secreted from, the surface of infective larvae. Pigs immunized with
this antigen are not protected from subsequent challenge infection. Experimentally
infected pigs or naturally infected humans do however mount a significant serological
antibody response to the antigen. These findings shed light on a glycolipid-like antigen
(As12) that is secreted by infectious Ascaris larvae and is targeted by the immune system
of infected humans and pigs.
Introduction
Ascaris lumbricoides is the most prevalent intestinal parasitic nematode of man, infecting
approximately 819 million people worldwide in developing countries [1]. Due to the high
degree of morphological and genetic similarity, it is still debated as to whether A. lumbricoides
from humans is a different species than A. suum from pigs [2–4]. Moreover, recent studies
have shown that pig Ascaris is a zoonosis [5–8]. Even though anthelmintic treatment remains
highly effective against A. lumbricoides, there is increased concern about the development of
anthelmintic resistance. In addition, the high risk of reinfections after treatment calls for the
development of new, long-acting solutions like vaccination. In addition, the development of
more rapid and sensitive diagnostic techniques that adequately reflect the level of Ascaris expo-
sure in a population could greatly improve our knowledge on infection dynamics and preva-
lence. Consequently, it would thus allow for a more precise estimate of the impact of infection
and a better evaluation of a given intervention.
Vaccination has proven to be the most efficient and cost-effective way of disease control
[9]. Vaccination against ascariasis should in theory be feasible since pigs, repeatedly infected
with A. suum, develop immunological responses at the level of the liver, lungs and intestine
that stop migrating larvae from reaching adulthood. Furthermore, repeated exposure to the
parasite induces an immunological response at the level of the intestine that is called the ’pre-
hepatic barrier’, eventually preventing newly acquired larvae from migrating to the liver [10,
11]. Recently, it has been shown that this immunity was associated with eosinophilia, mastocy-
tosis and goblet cell hyperplasia in the caecum, the place where the infective stage 3 larvae (L3)
penetrate the intestine and start their hepatopulmonary migration [12]. However, it is still
Ascaris Larval Glycolipid-like Antigen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005166 December 1, 2016 2 / 20
Competing Interests: The authors have declared
that no competing interests exist.
unclear which parasite products induce these immune responses or what the targets of these
responses are. An increased understanding on this matter could offer important information
for the development of protection by vaccination against this parasite.
The need for improved methods to diagnose Ascaris infections in pigs and humans has
recently been extensively discussed [13, 14]. It was suggested that diagnostic tools detecting
eggs in the stool are not useful for accurate evaluation of the level of exposure in pig farms [15]
or sensitive enough for the detection of infection in humans where prevalence was low [16].
Serological tools detecting exposure to Ascaris might be more sensitive than egg based diag-
nostics for measuring prevalence or intensity of exposure in a human community [17]. Until
now, only a handful of studies report the evaluation of antibody-based tests for ascariasis [18–
23]. Recently, Vlaminck et al., [15, 17] showed that an ELISA detecting antibodies to Ascaris
haemoglobin in plasma or serum samples appears to reflect general exposure to Ascaris on a
community or herd level in humans and pigs, respectively. However, more species-specific
antigens from early larval stages might increase the sensitivity and specificity of serological
assays or recognize infections at an earlier stage.
Hence, the main objective of this study was to use intestinal antibodies from pigs with a
proven pre-hepatic barrier to identify immunogenic proteins of the infective stage larvae of A.
suum and subsequently evaluate their protective and diagnostic potential.
Methods
Experimental animals
The piglets used in this study were female and castrated male Rattlerow Seghers hybrid pigs of
the local stock of the animal facility (Ghent University). They were approximately 10 weeks
old and weighed between 20 and 30 kg at the start of the trials. The pigs were raised indoors in
a helminth free environment and had free access to a commercial feed and water.
Parasite material
Adult female A. suum worms were collected from the intestines of naturally infected pigs from
commercial farms that were being processed as part of the normal work at a local abattoir in
Ghent, Belgium. Consent was acquired from abattoir management to collect the worms. Adult
female A. lumbricoides worms were collected from the stool of individuals after treatment with
anthelmintics in Jimma Town, Ethiopia [24].
Ascaris eggs were obtained by dissection of worm uteri and suspended in a 0.5% (w/v)
potassium dichromate solution to a volume of 50 ml and placed in a culture flask at a concen-
tration of 50 eggs/μl. The eggs were incubated at 27˚C in the dark until third stage larvae were
present and were subsequently used for infection trials or to extract infective stage-three larvae
(L3).
Fresh L3 were obtained from Ascaris eggs using the method described by Urban et al. [25].
In brief, Ascaris eggs, cultured in vitro were treated for 1 hr with commercial bleach and subse-
quently washed 3 times with phosphate buffered saline (PBS) of 37˚C after which the eggs
were transferred into an Erlenmeyer flask containing glass beads and a magnetic stir bar and
stirred very slowly (60 rpm) to induce hatching. After 15 min the suspension was poured onto
a layer of cotton wool placed on top a Baermann apparatus with PBS at 37˚C and left over-
night. The next day, the larvae in the neck of the funnel were collected and washed 3 times in
PBS. L3 extracts were prepared by grinding the collected larvae with a mortar and pestle that
was placed in a bath of liquid nitrogen. The larval homogenate was transferred to a 15 ml tube
and mixed with PBS and proteinase inhibitor cocktail (1:100) (Sigma, Diegem, Belgium). The
homogenate was then inverted at 4˚C for 2 hrs followed by centrifugation for 30 min at
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10,000g at 4˚C. The supernatant (L3 PBS) was removed and kept on ice. The pellet was resus-
pended in PBS with 0.05% Tween-20 solution and fresh proteinase inhibitor cocktail (1:100)
was added. The mixture was inverted at 4˚C for 2 hrs and the supernatant (L3 PBST) was
removed after centrifugation and stored on ice. Finally, the remaining pellet was resuspended
in PBS containing Triton X-100 (2%) and proteinase inhibitor cocktail (1:100) and subse-
quently inverted at 4˚C for 2 hrs followed by centrifugation. The supernatant (L3 Triton) was
collected and stored on ice. Subsequently, all extracts were sterilised by filtration (0.22μm) and
the filtrate concentrated at 4˚C using a Centriprep centrifugal filter with YM-3 membranes
(Millipore, Overijse, Belgium). Protein concentration was determined by the BCA method
(Pierce, Rockford, USA) and the extracts were stored at -80˚C until use.
In order to obtain L3 excretory-secretory (E/S) products, freshly obtained A. suum L3
were incubated at 37˚C and 5% CO2 at a concentration of 5,000 larvae/ml in DMEM with
4,5 g/L Glucose, L-Glutamine and Pyruvate (Thermo Fisher, Erembodegem, Belgium) con-
taining 1% Penicillin-Streptomycin (P/S) (5,000 u/ml Penicillin and 5,000 μg/ml Streptomy-
cin, Thermo Fisher), 1% Kanamycin (10000 μg/ml, Thermo Fisher), 1% Amphotericin B
(250 μg/ml, Sigma) and 0,5% Gentamicin (10 mg/ml, Thermo Fisher). The culture fluid was
collected daily and filtered using 0.2 μm membrane disc filters (Supor 200, Zaventem, Bel-
gium), concentrated and dialysed against PBS in an Ultrafiltration Stirred Cell (Millipore)
using a 10kDa cut-off filter membrane (Millipore). The L3 E/S material was then stored in
aliquots at -80˚C.
In order to obtain lung L3 and intestinal L4 and L5 stages, piglets were infected with
approximately 100,000 infective A. suum eggs and sacrificed 7, 14 and 28 days post-infection,
respectively. The lung L3 and intestinal L4 were collected from minced lung tissue or intestinal
content that was placed on a modified Baermann device as described by Slotved et al. [26]. L5
larvae were collected from the intestinal content by hand. Larvae were washed excessively
using PBS 4˚C and stored at -80˚C. Adult worms were collected from the intestines of infected
pigs from commercial farms that were being processed as part of the normal work at a local
abattoir in Ghent, Belgium. Protein extracts from all life stages were produced as described
above for the L3 stage. Finally, extracts from A. lumbricoides L3, were obtained after sonication
as previously described by Vlaminck et al., [27].
Inducing pre-hepatic immunity in pigs by experimental trickle infection
Eight pigs were divided into 2 groups of 4 pigs. Pigs of group B were trickle infected 5 times a
week with approximately 100 infective A. suum eggs in the feed for a period of 30 weeks. Pigs
of group A were used as challenge controls. Two other pigs were euthanized before the start of
the infection trial and used as negative controls. After the 30-week infection period, all pigs of
group A and B were treated with a single dose of 5mg/kg fenbendazole (MSD, Brussels, Bel-
gium). One week after treatment, all pigs were infected with 2,000 infective A. suum eggs. All
pigs were euthanized 14 days post challenge infection. During necropsy, the number of white
spots, characteristic lesions on the liver caused by migrating A. suum larvae, was recorded and
mesenteric lymph nodes from the small intestine, caecum and colon were collected and imme-
diately processed as described below. Pieces of small intestine of approximately 1 meter were
flushed three times with 50ml of PBS to rinse out all larvae in the intestinal lumen. The rinsing
solution was collected and passed over a 200 μm mesh sieve. The remaining debris on top of
the sieve was collected and examined for intestinal L4 larvae. After rinsing, the pieces of small
intestine and the caecum and colon were cut open longitudinally and washed gently with
excessive volumes of lukewarm tap water to remove any remaining intestinal content. Subse-
quently, mucus was collected by gently scraping the luminal side of the pieces of intestine with
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a microscope slide. During the experiment, blood samples for serum were collected from all
pigs every 2 weeks.
Isolation and in vitro cultivation of mononuclear cells from local intestinal
lymph nodes
Single-cell suspensions of mesenteric lymph node cells (LNC) were prepared by mechanical
disaggregation through a sterile stainless steel gauze. The LNC in ice cold PBS were centrifuged
at 150 g for 10 min at 4˚C, the supernatant removed and LNC resuspended in DMEM growth
medium supplemented with 4,5 g/L Glucose, L-Glutamine and Pyruvate (Thermo Fisher) con-
taining 1% P/S (Thermo Fisher). The mononuclear cells (monocytes and lymphocytes
(MNC)) were separated by the addition of LymphoPrep and centrifugation at 800g (without
brake) for 30 min at 4˚C. The MNC were collected from the interphase and washed twice with
DMEM + 1% P/S + 2% heat-inactivated foetal bovine serum (Moregate, Australia & New Zea-
land) and the cells were subsequently suspended in DMEMcomplete. (DMEM + 1% P/S + 1%
Non-Essential Amino Acids (Thermo Fisher), 1% Kanamycin (10 mg/ml, Thermo Fisher), 1%
Amphotericin B (250 μg/ml, Sigma) and 0.1% of a 0.35% β-mercaptoethanol solution). Viable
MNC were counted, the concentration adjusted to 5.0 106 cells/ml in DMEMcomplete and cul-
tured for 4 days in tissue culture flasks at 38˚C and 5% C02. Finally, the culture supernatant
(SN) was collected, filtered using 0.2 μm membrane disc filters (Supor 200), concentrated
using Centriprep centrifugal filter units with YM-3 membranes (Millipore) and stored in ali-
quots at -80˚C.
Purification of antibodies from mucus
An equal volume of ice-cold PBS was added to the mucus collected from small intestine, cae-
cum and colon and subsequently homogenised using an Ultrathurax mixer (2 min at 15,000
rpm). This mixture was then centrifuged for 15 min at 10,000g at 4˚C, the supernatant was col-
lected and centrifuged again as before. After this second centrifugation step, the supernatant
was stored at -80˚C. At a later time, antibodies were purified from this supernatant using Pro-
tein-A agarose beads (Sigma) following the manufacturer’s protocol. Purified mucosal anti-
bodies were stored at -20˚C until used.
SDS-PAGE, Western blotting and staining procedures
Protein extracts (5 μg) were mixed with 5x sample buffer (60 mM Tris-Cl pH6.8, 2% SDS, 10%
glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue) and put into a boiling water bath
for 5 min. Afterwards, the samples were applied to 15% SDS-PAGE gels and separated by elec-
trophoresis in Tris-Glycine buffer (Tris 250mM, Glycine 200mM, SDS 1% w/v). Protein bands
were visualized using SimplyBlue Safestain (Thermo Fisher) or SilverStain kit (Thermo
Fisher). Glycoproteins were stained by the use of the ProQ Emerald 300 gel stain kit (Thermo
Fisher).
For Western blotting, SDS-PAGE gels were blot transferred to PVDF membranes (Milli-
pore) or nitrocellulose membranes (Thermo Fisher) and blocked in PBS + 0.2% Tween80
(PBSt80) or in PBS + 0.2% Tween20 (PBSt20) + 5% Blotting-Grade Blocker (BioRad). The
blots were probed for 2 hrs (1ml/lane PBSt80 containing approximately 5 μg/ml antibodies
purified from mucus or the concentrated culture supernatant of MNCs). The following conju-
gates and dilutions were used: goat anti-pig IgG-HRP conjugated (Sigma) (1/10,000), goat
anti-pig IgA-HRP (Abcam, Cambridge, UK) (1/5,000). The immunoreactive antigens were
visualised by chemiluminescent substrate (5ml 0.1M Tris pH 8.6 + 11μl 90mM p-coumaric
acid (Sigma) + 25μl 250mM luminol (Sigma) + 15μl of 10% (v/v) H2O2).
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Purification of the L3 total lipids
L3 PBS extract was subjected to a Folch method [28] for the extraction of total lipids. In short,
L3 PBS extract was mixed with chloroform/methanol (2/1) to a final volume 20 times the vol-
ume of the original extract and incubated for 20 min. The homogenate was centrifuged and
the liquid phase recovered and washed with 0.2 volume of 0.9% NaCl solution. The mixture
was centrifuged at 2,000 rpm to separate the two phases. Both upper and lower phases were
collected separately and evaporated at 90˚C under a fume hood. The dried lipid pellets were
stored at -80˚C until further use.
Chemical and enzymatic degradation of the L3 PBS extract and As12
To investigate the composition of the As12 antigen, total L3 PBS extract was incubated with
different enzymes and submitted to different chemical treatments. For the enzymatic degrada-
tion, the L3 PBS extract was treated overnight at 37˚C with pronase, lipase and trypsin at pH
8.0 and pepsin at pH 3.0 (all from Sigma). Additionally, L3 PBS extract was treated overnight
at 37˚C or 60˚C in 20mM periodic acid, 1M NaOH, 1M Trifluoracetic acid and 1M HCl or in
PBS at 37˚C, 60˚C or 90˚C. Purified As12 was treated in 48% aqueous HF at 4˚C for two days,
then lyophilized and used for Western blotting. The presence of phosphorylcholine (PC) on
the antigen was confirmed by screening with TEPC-15 monoclonal IgA antibodies (Sigma) on
western blot. The deglycosylation of The L3 PBS extract with PNGase F was performed under
denaturing conditions according to the manufacturers’s protocol (Promega). RNAse B was
used for treatment control. The As12 antigen was also incubated in 50mM NaPO4, pH 5.0 for
2 days at 37˚C with 0.1 unit ß-N-acetylglucosaminidase from jack bean (Sigma). After incuba-
tion, samples were boiled in 5x sample buffer, run on SDS-page, blotted onto PVDF mem-
branes (Millipore) and recognition of the As12 antigen checked by incubation with mucosal
antibodies from pigs of group B with 5μg/ml of antibodies/lane.
Glycan analysis
For glycan analysis, aliquots of As12 were treated with PNGase-F, -A and chemical β-elimina-
tion to release N- and O-glycans, respectively. Released glycans were analysed by MALDI--
TOF-MS after derivatisation with 2-aminobenzoic acid or permethylation, as described
previously [29, 30].
Monosaccharide composition analysis
Approximately 2 μg As12 was hydrolysed in a glass vial with 50 μl 4 M TFA at 100˚C for 4 hrs,
dried under nitrogen, then monosaccharides labelled with 10 μl 2-aminobenzoic acid (2-AA)
labelling mix (48 mg/ml 2-AA, 1 M 2-picoline-borane dissolved in 30% acetic acid / DMSO)
followed by 2 hrs incubation at 65˚C. For HPLC, 10 μl labelled sugars was added to 90 μl 0.6%
sodium acetate, and 25 μl applied to a Superspher 100 RP-18 column 250 x 4 mm (Merck).
Buffers were: A = 0.1% butylamine, 0.5% phosphoric acid, 1% tetrahydrofuran; B = 0.05%
butylamine, 0.25% phosphoric acid, 0.5% tetrahydrofuran, 50% acetonitrile. Run conditions
were 0.5 ml/min, starting at 8% buffer B for 5 min, 8–25% buffer B over 25 min, 25–100% B
over 2 min, maintained for 10 min. Monosaccharide standards (500 pmol Glc, Gal, Man, Fuc,
Xyl, GlcNAc, GalNAc) were treated with TFA, labelled, and ran as above.
Antibody labelling of larvae
A total of 40,000 L3 were incubated for 1 hr at 37˚C in 1ml RPMI (Thermo Fisher) with 20μg
purified mucosal antibodies from pigs from group A, group B and from negative controls or
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with TEPC-15 antibodies (Sigma) at a concentration of 1/500. After the incubation, larvae
were washed three times with 1ml RPMI 37˚C before being resuspended for 30 min in 1ml
RPMI at 37˚C containing FITC labelled anti-pig IgG (Bethyl laboratories, Montgomery, TX,
USA) at a concentration of 1/1,000 or FITC labelled anti Mouse IgA at a concentration of 1/
2,000 (Thermo Fisher). All incubations with FITC-conjugated antibodies were conducted in
the dark. Finally, the larvae were washed four times with 1ml of PBS 37˚C to remove any
remaining secondary antibodies and put on a glass slide for fluorescent microscopy analysis.
All labelling experiments were performed in triplicate.
To determine whether the stained L3 actively shed the As12 antigen, larvae were stained
with 20μg of purified mucosal antibodies from pigs from group B as described above. After
staining and washing, half of the larvae were killed by freezing them for 10 min at -80˚C. The
other half was kept in RPMI at 37˚C. After this, the number of stained larvae in 3 aliquots of
both groups was counted by fluorescence microscopy. This assessment was repeated after 1, 2,
3, 4 and 24 hrs.
Vaccination experiment in piglets
Twelve piglets (approximately 10 weeks old) were divided into two groups of 6 pigs. Each pig
in Group A was vaccinated with total lipid fraction purified from L3 PBS extract that was
obtained from 200,000 L3 and dissolved in 0.5 ml sterile PBS + 0.5 ml Alhydrogel (AlOH). The
control pigs of group B were injected with 0.5 ml sterile PBS + 0.5 ml AlOH. Pigs were immu-
nized three times by intramuscular injection at day 0, 14 and 28 of the experiment. One week
after the final immunization, all pigs were experimentally infected with 1,000 infective A. suum
eggs in 5ml of tap water by oral intubation. Two weeks after infection, at day 49 of the experi-
ment, all pigs were euthanized and L4 larvae were recovered from the small intestine as
described above and counted. Blood samples were taken at the start of the trial, one week after
the third immunization and at the time of necropsy to evaluate seroconversion against the
As12 antigen following vaccination.
ELISA
Indirect ELISA determined antibody recognition of the As12 antigen by pig sera or human
plasma samples. ELISA plates were coated with antigen overnight in carbonate buffer (pH 9.6)
at 4˚C. Plates were coated with 1μl/ml of total lipid extract purified from 200,000 L3 which was
dissolved in 50μl UPW. After three washes with PBSt, the plates were blocked with 100μl/well
blocking buffer (5% milk powder (w/v) or 5% heat treated fetal calf serum in PBS) for 2hrs at
4˚C. Sera or plasma samples were added in duplicate at a dilution of 1/250 in PBSt for 2hrs at
4˚C. The plates were washed again as before and incubated with the conjugate (goat anti-pig
IgG-HRP (Sigma) (1/10,000), goat anti-human IgG4-HRP (Southern biotech) (1/2,000)) in
blocking buffer. Plates were incubated for 1hr at 37˚C. O-phenylenediamine 0.1% in citrate
buffer (pH 5.0) served as substrate and after a 10 min incubation period in the dark, the devel-
opment reaction was stopped by adding 50μl of 4M H2SO4 to all wells and optical density
(OD) was measured at 490 nm.
Sera from the trickle infected pigs described above were used to evaluate antibody response
over time. Additional pig sera were obtained from an experimental infection trial performed
by Nejsum et al., [31] where piglets 10 weeks of age were infected twice a week in the feed for a
total of 14 weeks with A. suum and Trichuris suis (25 and 5 embryonated eggs kg−1 day−1,
respectively). Serum and faecal samples were collected at the start of the trial (W0) and 7 (W7)
and 14 (W14) weeks after the first infection. Pigs were euthanized 14 weeks after the start of
the experiment and the number of macroscopic worms present in the small intestine counted.
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The negative control was a pooled serum sample from 4 10-week old piglets without previous
exposure to A. suum. The positive control was a pooled serum sample from 4 pigs after 14
weeks of daily infection with 100 A. suum eggs [12]. Reactivity of pig sera to the antigen is
shown in ODr (Optical Density ratio). (ODr sample = (OD sample−OD negative control) /
(OD positive control−OD negative control)).
Plasma samples from A. lumbricoides infected humans were collected as previously
described [32] from individuals living in Mainang village on Alor Island (Province of East
Nusa Tenggara, Timor, Indonesia), an area with high Ascaris prevalence (>30%). A subset of
25 plasma samples of which all individuals had A. lumbricoides eggs in their stool was evaluated
for anti-As12 IgG4 antibodies. A total of 24 plasma samples from individuals with hookworm
infection used in this study were from people living in the East Sepik region of Papua New
Guinea where A. lumbricoides was not present. Non-endemic control sera were from Ameri-
can subjects in St. Louis, MO, USA. Reactivity of human sera to the As12 antigen is shown in
OD.
Binding of anti-PC antibodies to As12
TEPC-15 antibodies (Sigma) or pooled mucosal antibodies of pigs from group B of the trickle
infection experiment were dissolved in PBSt at a dilution of 1/250 or 10μg/ml respectively and
subsequently pre-incubated with PC-Cl salt (Sigma) at different concentrations (0, 10, 25 μg/
ml final concentration) for 30 min at room temperature. Following pre-incubation, the anti-
body mixtures were added to an As12-coated ELISA plate for 2hrs at 4˚C. After washing the
plates three times with PBSt, the TEPC-15 antibodies were detected by HRP labelled anti
Mouse IgA at a concentration of 1/2,000 (Bethyl laboratories) and the mucosal antibodies
were detected by HRP conjugated goat anti-pig IgG (Sigma) at a 1/5,000 dilution in blocking
buffer for 1hr at 37˚C. Finally, the plates were washed, developed and read as described above.
Statistical analysis
All statistical analyses were performed using Graphpad Prism 6.0e for MacOSx. The Mann-
Whitney U-test for pairwise comparison was used to compare the group means of the immune
pigs and the challenge controls during the vaccination trial or to compare anti As12 antibody
levels between different groups of human or pig plasma or serum samples. T-tests were per-
formed to test for differences in the percentage of stained larvae or antibody reactivity of the
two different experimental groups during the vaccination experiment. A paired t-test was used
to detect the first time point at which infected pigs showed a significant higher ELISA reactiv-
ity to As12 antigen compared to the start of infection. Possible correlations between antibody
responses and parasitological data (EPG or worm counts) were assessed using the Spearman’s
rank correlation coefficient. The use of computed Receiver Operating Characteristic (ROC)
curves allowed for the determination of test sensitivity and specificity and to select an appro-
priate cut-off. Probability (P) values< 0.05 were considered to indicate significant differences.
Ethical clearance
All animal experiments were conducted in accordance with the E.U. Animal Welfare Direc-
tives and VICH Guidelines for Good Clinical Practice. Ethical approval to conduct the studies
was obtained from the Ethical Committee of the Faculty of Veterinary Medicine, Ghent Uni-
versity. The collection of adult A. lumbricoides worms was performed during a trial performed
by Mekonnen et al., in 2013 [24]. This study was approved by the ethical committee of Jimma
University, Ethiopia, Ghent University and Antwerp University, Belgium. The Ethical Com-
mittee of the University of Indonesia, Jakarta approved the Alor Island study as previously
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described [32]. The Human Investigations Institutional Review Boards of Case Western
Reserve University and the Papua New Guinea Medical Research Advisory Committee
approved all protocols. The Institutional Review Board at Washington University School of
Medicine in St. Louis, MO, USA approved our use of anonymized patient samples for the
development of serological tests for helminth infections. Since written consent is not consis-
tent with cultural norms on Alor Island, oral informed consent was obtained from all adults
or, in the case of children, from their parents. The participant’s oral consent was noted on a
survey questionnaire. The ethical board of the University of Indonesia and the institutional
review boards in Germany and the USA approved the use of oral consent.
Results
Immunization of pigs by trickle infections
Immunity was induced in 4 pigs (Group B) trough trickle infection with 100 A. suum eggs 5
times a week for a period of 30 weeks. After a subsequent challenge infection with 2,000 infec-
tive A. suum eggs, the number of larvae and liver white spots were significantly reduced in
these pigs when compared to control pigs who were not trickle infected (Group A) (Table 1).
Challenge control pigs from Group A showed an average of 72.5 ± 43.3 liver white spots and
105 ± 81.3 L4’s in the intestine. In contrast, immunized pigs showed a 99% reduction in num-
ber of white spots on the liver (2.0 ± 1.8) and a 100% reduction in the number of L4 stage lar-
vae in the intestine 2 weeks post-challenge, indicating the presence of intestinal immunity
against infectious A. suum L3 in these pigs.
Local antibody responses of immune pigs to L3 extracts
Antibodies from the intestinal mucus and from MNC culture supernatant were used to detect
immunogenic antigens in A. suum L3 protein extracts (Fig 1). Several antigens were recog-
nized by IgG and IgA antibodies isolated from both the challenge control pigs and the trickle
infected pigs. One zone of approximately 12kDa in size was recognised by IgG and IgA anti-
bodies from the immunized pigs (Group B). Although this zone was also detected by the chal-
lenge control animals (Group A), recognition was generally much more intense in the
immune animals (Group B). This antigen, from here on out referred to as As12, was also
detected in the water-insoluble protein fractions of L3 (S1 Fig). In addition, there was also
increased recognition of a 21kDa antigen in the L3 PBS extract by mucosal IgA antibodies of
immunized pigs.
Presence of As12 in different life stages of A. suum and A. lumbricoides
An immunoblot of the PBS extracts of the different life stages of A. suum showed that the rec-
ognition of the As12 antigen was restricted to the early L3 stage and its E/S products (Fig 2A).
The antigen was absent from the lung stage larvae onwards. In the L3 PBS extract from A. lum-
bricoides, a band of the same molecular weight as As12 was recognised (Fig 2B).
Table 1. Long term trickle infection of pigs with A. suum results in reduced liver white spots and L4 recovered from the small intestine 14 days
post challenge infection with 2,000 infective eggs.
Group n Immunization protocol (30 weeks) White spots L4
A 4 No infection 72.5 ± 43.3 105.0 ± 81.3
B 4 100 eggs/day, 5 days/week 2.0 ± 1.8* 0.0 ± 0.0*
* Significant difference when compared to control group (Group A) (P<0.01).
doi:10.1371/journal.pntd.0005166.t001
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Properties of As12
The As12 antigen could be visualised by a staining for carbohydrates or after immunoblotting
but not by conventional protein staining methods like silver staining or coomassie staining
(Fig 3A). The As12 antigen could be purified from the L3PBS protein extract by performing a
Folch extraction for the isolation of total lipid. The antigen appeared to be the sole recognized
antigen in both the upper methanol and lower chloroform phase after Folch extraction
(Fig 3A).
To further explore the specific properties and composition of the As12 antigen, the antigen
was subjected to different chemical and enzymatic treatments. The immunoblot reaction to
the As12 antigen by purified mucosal antibodies following exposure of the L3 PBS extract to a
range of chemical and enzymatic treatments is shown in Fig 3B. Overnight treatment of the
L3PBS extract with pronase, lipase, trypsin or pepsin did not affect antibody recognition of the
As12 antigen. Similarly, heating the L3PBS extract to 60˚C or 90˚C overnight did not reduce
the recognition of As12, as well as treatment with 1M NaOH. Incubating the L3 PBS antigen
with PNGaseF to cut off N-linked glycan structures or subjecting it to ß-N-acetylglucosamini-
dase treatment for the liberation of terminal ß-linked N-acetylglucosamine and N-acetylgalac-
tosamine residues also did not diminish the recognition of the As12 antigen. The only
chemical reactions that reduced or prevented recognition of As12 by porcine antibodies were
treatment with 20mM periodic acid at 37˚C or 60˚C or 1M trifluoracetic acid and 1M HCl at
60˚C. Finally, treatment of the As12 fraction with 48% HF for 48 hrs at 4˚C for the removal of
Fig 1. The detection of a 12kDa A. suum L3 antigen in the L3 PBS extract by intestinal antibodies. IgG
and IgA antibodies purified from the supernatant of purified mononuclear cells (MNC) from mesenteric lymph
nodes or the intestinal mucus were used to screen the L3 PBS extract on Western blot. Antibodies from
immune pigs (Group B) strongly react to an antigen migrating at 12 kDa. Pigs from the challenged control
group (Group A) also had antibodies against the 12kDA antigen, but the reactivity on Western blot was lower
than in immune pigs. Conjugate alone (cc) did not react with the antigen.
doi:10.1371/journal.pntd.0005166.g001
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any PC groups on the antigen also reduced the immune recognition. The presence of a PC
group on the As12 antigen was further confirmed by Western blot using specific anti PC anti-
bodies (TEPC-15) (Fig 3C). Next to the As12 antigen, several other PC-bearing antigens were
detected in the A. suum L3 extract.
Mass spectrometric analysis of glycans released from As12 after enzymatical treatments
with PNGase-F and -A or by chemical β-elimination provided no indications for the occur-
rence of common N- or O-glycans on As12. Monosaccharide composition analysis indicated
that the glycan portion of As12 consists mainly of GalNAc and GlcNAc in an approximate 1:2
ratio, with a minor amount of Glc (S2 Fig).
Fig 2. The As12 antigen is produced and secreted by the early L3 stage of A. suum and is also present
in A. lumbricoides L3. (A) The detection of the As12 antigen by IgG antibodies purified from the intestinal
mucus of A. suum immune pigs in PBS extracts of different A. suum life stages (Egg L3, L3 E/S, Lung L3, L4,
L5, Adult male and female worms) and (B) in the PBS extract of A. suum and A. lumbricoides L3.
doi:10.1371/journal.pntd.0005166.g002
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Immunolocalization
Freshly hatched A. suum L3 were incubated with antibodies purified from the intestinal mucus
of immunized pigs (Group B). On Western blot these antibodies mainly recognized the As12
antigen (Fig 3C). Antibodies bound to the surface were detected with FITC labelled anti-pig
total IgG. This showed complete staining of the outer surface of larvae that had shed their L2
sheath (Fig 4A). Other larvae with partially shed L2 sheaths showed only incomplete staining
(Fig 4B). To further verify that the reactivity with mucosal antibodies was directed against the
As12 antigen, L3 larvae were also incubated with monoclonal antibodies directed against PC.
This labelling also resulted in staining of the L3 surface (Fig 4C). Live L3 appear to shed off the
antigen-antibody complexes (Fig 4D). As a consequence, the number of L3 stained by mucosal
antibodies diminished significantly over time when stained larvae were kept alive in culture. In
contrast, when larvae were killed after staining, the number of stained L3 did not diminish
over time (Fig 4E).
Evaluation of As12 as a vaccine antigen
Results of the vaccination trial with the As12 antigen are shown in Fig 5A. Immunizing pigs
with the total purified lipid fraction from A. suum L3, containing the As12 antigen, did not
seem to induce protection to subsequent homologue challenge infection. There was no signifi-
cant difference in number of liver white spots or number of L4 recovered from the intestine 14
Fig 3. Exploring the properties and composition of the As12 antigen. (A) Coomassie staining, carbohydrate staining and
Western blot developed with mucosal IgG antibodies from immune pigs (Group B) of the complete L3PBS extract (1), the
pellet after Folch extraction (2), the upper ‘methanol phase’ (3) and the lower ‘chloroform phase’ (4). (B) Recognition of the
As12 antigen by mucosal IgG antibodies from immune pigs after chemical or enzymatic treatments of the A. suum L3 PBS
extract: untreated (1&17); overnight digestion at 37˚C with pronase (2); lipase (3); trypsin (4); pepsin (5); overnight incubation
at 37˚C (6), 60˚C (7) and 90˚C (8); overnight incubation with 20mM periodic acid at 37˚C (9) and 60˚C (10), 1M NaOH at 37˚C
(11) and 60˚C (12), 1M trifluoracetic acid at 37˚C (13) and 60˚C (14); 1M HCl at 37˚C (15) or 60˚C (16); 48 hrs incubation in
48% HF at 4˚C (18); overnight incubation at 37˚C without (19) or with PNGase-F (20) and 48 hrs. incubation at 37˚C with (21)
or without (22) Jack Bean ß-N-Acetylglucosaminidase. (C) Recognition of A. suum L3 PBS antigens by purified mucosal IgG
antibodies from immune pigs (1) and specific anti-phosphorylcholine antibodies (TEPC-15) (2).
doi:10.1371/journal.pntd.0005166.g003
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days after a challenge infection with 1,000 infective A. suum eggs. Pigs of the vaccinated group
did however show a significantly stronger IgG response against the As12 antigen compared to
control pigs (Fig 5B).
Evaluation of As12 as a diagnostic antigen for ascariasis in pigs and
humans
To evaluate whether the As12 antigen could serve as a serodiagnostic antigen to measure expo-
sure to Ascaris, the serum IgG antibody responses against the As12 antigen in the immunized
pigs of group A was measured over time (Fig 6A). Anti-As12 antibodies were significantly ele-
vated from 6 weeks after initial infection. Subsequently, sera from 91 experimentally infected
pigs (31) were analysed using the As12 ELISA and showed that the reactivity to the As12 anti-
gen increased significantly in pigs that were continuously infected with A. suum eggs (Fig 6B).
After ROC analysis, using the week 0 sera as Ascaris-negative and both week 7 and week 14
sera as Ascaris positive, the cut-off for positive individuals was placed at an ODr of 0.50. Using
this cutoff, the sensitivity of the ELISA was 98.4% (95% CI: 95.3–99.7), the specificity was
95.5% (95% CI: 88.9–98.8%) and the area under the curve was 0.99 (± 0.049). No relationship
was found between anti-As12 antibody levels and the faecal egg count after 7 or 14 weeks of
trickle infection or the number of adult worms at necropsy.
Fig 4. Mucosal antibodies from immune pigs recognize antigens on the surface of A. suum L3 that likely
contain phosphorylcholine groups and are actively secreted by living larvae. (A) UV-microscopy images
(400x) of A. suum L3 larvae stained by mucosal antibodies from naïve pigs, challenge control pigs (Group A) or
immunized pigs (Group B) and incubated with FITC labeled anti-pig IgG. (B) UV-microscopy image (400x) of A.
suum L3 larva partially stained by mucosal antibodies from immune pigs and incubated with FITC labeled anti-pig
IgG. (C) A UV-microscopy image (400x) of an A. suum L3 larva stained by anti-PC antibodies and (D) a stained
larva in the process of shedding these antigen-antibody complexes. (E) The percentage of A. suum L3 stained by
mucosal antibodies from immune pigs decreased over time when L3 were kept alive in culture media (dotted line)
but not when L3 were killed after staining (full line) (P < 0.01).
doi:10.1371/journal.pntd.0005166.g004
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We subsequently tested whether the antibody reactivity to As12 was solely directed against
the presence of PC on the antigen. For this, both specific anti-PC monoclonal antibodies
(TEPC-15) and pooled purified mucosal antibodies from trickle infected pigs were pre-incu-
bated with increasing concentrations of PC-Cl salt to block the PC-binding sites. After pre-
incubation, antibody preparations were used to detect As12 by ELISA. Pre-incubation of
TEPC-15 antibodies with increasing concentrations of PC-Cl salt reduced binding reactivity to
As12 in a concentration dependent way (Fig 6C). Although pre-incubation with PC-Cl salt
also affected the binding reactivity of pooled purified mucosal antibodies, the relative level of
inhibition was not as pronounced as for the TEPC-15 antibodies (79% vs 27% and 91% vs 51%
reduction of recognition at 10 and 25μg/ml PC-Cl salt respectively). This suggests that the rec-
ognition of As12 by Ascaris infected pigs was not solely directed against PC.
Finally, the use of As12 as a serodiagnostic antigen was also validated with human samples.
Twenty five human plasma samples from Indonesia from patients with proven A. lumbricoides
infection (EPG >50) were analysed using the As12 ELISA (Fig 6D). In addition, 20 non-
endemic plasma samples (USA) were used as negative controls and 24 plasma samples from
individuals with hookworm infection were tested to evaluate possible cross reactivity. The lev-
els of anti-As12 IgG4 in the human samples was significantly elevated in humans infected with
A. lumbricoides. ROC analysis placed the optimal cut-off for the human As12 ELISA at an OD
of 0.26. Using this cut-off, the sensitivity of the ELISA was 92.0% (95% CI: 74.0–99.0%), the
specificity was 90.0% (95% CI: 68.3–98.8%) and the area under the curve was 0.96 (± 0.026). A
total of 24 out of 25 Ascaris infected individuals (96%), 2 out of 20 non-endemic plasma sam-
ples (10%) and 2 out of 24 hookworm infected individuals (8.3%) were positive for anti-As12
IgG4 antibodies when this cut-off was employed.
Fig 5. Vaccinating pigs with a purified As12 fraction in combination with AlOH adjuvant does not induce
protection against subsequent challenge infection despite increased serum antibody responses to the
antigen. (A) The number of white spots counted on the liver and the number L4 recovered from the small intestine at
necropsy 14 days after a challenge infection with 1,000 infective A. suum eggs in 6 pigs vaccinated with As12 + AlOH
(Group A) and 6 adjuvant control pigs (GroupB). (B) The total IgG response in the serum directed against the As12
antigen fraction was significantly elevated in the vaccinated group one week after the third immunization, at the time of
infection (Day 35) and the day of necropsy (Day 49) in comparison to the adjuvant control group (P < 0.01).
doi:10.1371/journal.pntd.0005166.g005
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Discussion
This study describes the identification and characterisation of As12, a phosphorylcholine-
containing glycolipid-like structure present on the surface of infective Ascaris L3 larvae. This
antigen is targeted by the intestinal antibody response of pigs that have been previously
exposed to infection. Both IgG and IgA isotype antibodies against As12 were produced by
local antibody secreting cells and both Ig isotypes were detected in the mucus of infected
pigs. Recognition of As12 seems to increase over time when pigs are continuously exposed to
infection. The As12 antigen was also found in A. lumbricoides L3 and is being recognized by
IgG4 from A. lumbricoides infected humans. As a result, an As12 based ELISA test could
identify 98% of the Ascaris exposed pigs and 92% of Ascaris infected humans, whereas
Fig 6. Pigs and humans infected with Ascaris develop antibodies to the As12 antigen. (A) The total IgG response to the As12 purified
fraction over time in pigs exposed to trickle infections (500 A. suum eggs/week) over a 30-week time period shows significantly higher IgG
responses from 6 weeks after the first challenge infection onwards (P < 0.05). (B) The serological response to the As12 fraction of 91
experimentally infected pigs increased significantly after 7 and 14 weeks of infection (P < 0.001). The optimal cut-off was determined by ROC
analysis and set at 0.50 (dotted line). (C) Relative ELISA recognition of As12 by either TEPC-15 monoclonal antibodies or purified mucosal
IgG antibodies from trickle infected pigs from group B after pre-incubation with increasing concentrations of PC-Cl salt (0, 10 and 25 μg/ml).
(D) Total IgG response against As12 was significantly higher in the 25 A. lumbricoides infected humans than in the 20 uninfected or 24
hookworm-infected individuals (P < 0.001). The cut-off was set at an OD of 0.26 by ROC analysis (dotted line).
doi:10.1371/journal.pntd.0005166.g006
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samples from non-endemic humans or hookworm infected individuals were negative except
for two samples in each case.
An amorphous envelope called the surface coat covers the L3 cuticle surface and it presents
the greatest interface between the parasite and its host. Our results suggest that the As12 anti-
gen is likely to be a component thereof. The surface coat or “fuzzy coat” is not derived from
the cuticle but from specialized secretory glands. It is rich in carbohydrates, is dynamically
responsive to changing host environments or immune attack and can be rapidly shed upon
binding by antibodies and/or immune cells [33–35]. This process of shedding seems to be
actively regulated in A. suum L3 since no decrease in staining was seen in dead L3 stained with
immune pig antibodies whereas the percentage of live stained L3 decreased significantly over
time. Similarly, antibody recognition of surface antigens on Toxocara canis L3 or Onchocerca
cervicalis microfilaria was also lost in a temperature dependent manner or after incubation
with antimetabolites [36, 37]. This process of sloughing off antibody-bound antigens is likely
to be one of the mechanisms used by Ascaris L3 in order to evade host immune responses. The
high antigenicity of the As12 antigen, presented on the L3 cuticle surface, might engage the
host immune system while the active shedding of the antigen after antibody binding prevents
actual protective mechanisms to damage the mobile larvae. The antigen might also be actively
secreted to influence the responses of nearby immune cells.
The 35 kDa carbohydrate antigen (CarLA) detected on L3 of the sheep parasite Trichostron-
gylus colubriformis [38] shows characteristics similar to As12 as it is also very resistant to multi-
ple enzymatic and chemical treatments, except for those that targeted carbohydrate structures.
Although no glycans were detected following PNGase-F and -A digestion or chemical β-elimi-
nation, monosaccharide analysis indicated a simple composition suggesting a more polysac-
charide nature with repeating units composed of GalNAc and GlcNAc.
Just like As12, CarLA is solely produced and excreted by the infective L3 stage and not by
any other life stage [39]. However, unlike As12, the CarLA antigen does not appear to possess
any PC group [38]. This might explain why the As12 antigen could not be recognized by
immune sheep sera or monoclonal antibodies directed against CarLA. The presence of a PC
hapten is very common on nematode carbohydrates attached to a protein or lipid backbone.
Previous studies have suggested that PC containing glycolipids from adult Ascaris worms have
immunomodulatory properties [40–42]. It is possible that this As12 antigen has similar prop-
erties, but further research is required to confirm this.
Despite the apparent antibody response against As12 in vaccinated pigs, there was no pro-
tection against subsequent challenge infection. A recent study by Masure et al., [12] has shown
strong eosinophil presence in the intestinal tissue of pigs which have developed a ‘pre-hepatic
barrier’. Possibly, the vaccination failed to induce an effective local intestinal cellular response
which appears necessary to kill and thereby prevent the worms from migrating. Furthermore,
systemic vaccination might not have induced the production of anti-As12 antibodies at the
level of the intestine, where immune-mediated killing of the larvae is expected to occur [12].
We recognize the unfortunate fact that the presence of anti-As12 antibodies in intestinal
mucus was not evaluated in this experiment. It is likely that the synergetic cooperation
between both antigen specific antibodies and cellular responses at the site of infection is key in
stopping the migrating larvae.
The strong antibody responses that are mounted by the host against As12 may be useful for
diagnostic purposes. Nearly all trickle-infected pigs showed strong development of anti-As12
antibodies, independent of whether they were harbouring adult worms in their gut or not. The
onset of detectable antibodies was however first apparent after 6 weeks, which is similar to
purified Ascaris haemoglobin antigen [15]. Infected humans also mounted a significant anti-
body response to the As12 antigen, whereas non-endemic or hookworm infected humans did
Ascaris Larval Glycolipid-like Antigen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005166 December 1, 2016 16 / 20
not seem to recognize the antigen. This result, together with the fact that pre-incubation with
PC-Cl salt of mucosal antibodies from trickle infected pigs did not completely prevent binding
of As12 on ELISA suggests that recognition of As12 not only depends on the PC-group but
possibly involves other parts of the antigen. More tests with sera from individuals with other
well-characterized helminth infections need to be performed to further determine the species
specificity of As12 as a serodiagnostic antigen.
In conclusion, in this study we used locally secreted antibodies from the intestine of pigs
with a pre-hepatic immunity to identify one major immunodominant antigen in the extracts
and E/S material of infective Ascaris L3. This As12 antigen is stage specific, of a glycolipid
nature and is being actively secreted. Experimentally infected pigs or naturally infected
humans develop a measurable antibody response against the As12, advocating its possible use
as a diagnostic antigen. The exact structure of this antigen and its biological role during infec-
tion is yet unknown and deserves further clarification.
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